While determinants of aortic pulse wave velocity (aPWV) are well known, much less is known about factors affecting lower-extremity pulse wave velocity (lePWV). Unlike aPWV, increased lePWV does not predict cardiovascular risk, but limits lower-extremity blood flow and is associated with increased left ventricular mass. The aim of this study was to compare the effect of cardiovascular risk factors on aPWV and lePWV. A total of 911 individuals from the Czech post-MONICA study (a randomly selected 1% representative population sample, mean age 54 ± 13.5 years, 47% men) were examined. Pulse wave velocity was measured using the SphygmoCor device. Aging had a large effect on aPWV, but only a small effect on lePWV. After adjustment for covariates, we observed that hypertension, diabetes, chronic kidney disease and dyslipidemia were positively and significantly associated with aPWV. However, only hypertension had a significant effect on lePWV. Increased ankle systolic blood pressure was associated with increased aPWV independently of brachial blood pressure. Ankle systolic blood pressure was more closely related to aPWV than lePWV. Subjects with an ankle-brachial index o1.0 had higher aPWV and lower lePWV compared with individuals with a normal ankle-brachial index. Lower-extremity arterial stiffness is affected by age and cardiovascular risk factors to a lesser extent than aortic stiffness. Increased ankle systolic blood pressure is linked not only to increased lower-extremity arterial stiffness, but also increased aortic stiffness. In subjects with a low ankle-brachial index, lower-extremity arterial stiffness is spuriously decreased.
INTRODUCTION
Aortic pulse wave velocity (aPWV) as a measure of aortic stiffness is an independent predictive factor for all-cause and cardiovascular morbidity and mortality in patients with various levels of cardiovascular risk. 1 In contrast, stiffness of other arterial territories has a smaller or no ability to predict cardiovascular outcomes. [2] [3] [4] [5] [6] Indeed, carotid stiffness has been shown to predict cardiovascular events in patients with end-stage renal disease 2 and after renal transplantation. 3 However, in patients with manifest cardiovascular disease, carotid stiffness was not an independent risk factor for vascular events. 4 Brachial and femoro-tibial PWV were not predictors of cardiovascular mortality in patients with end-stage renal disease. 5 Furthermore, only carotid-femoral PWV was independently associated with coronary artery calcification, carotid and femoral plaques, whereas carotidradial and femoro-tibial PWV were not. 6 On the other hand, femoral artery stiffness was found to be closely associated with symptoms of lower limb peripheral arterial disease (PAD). 7 Furthermore, a negative correlation was shown between brachial-ankle PWV and blood flow in the popliteal artery, 8 and between femoral arterial stiffness and foot transcutaneous oxygen tension. 9 Lately, increased lower-extremity PWV (lePWV) determined by a high ankle-brachial index (ABI) was found to be linked to greater left ventricular (LV) mass through nonatherosclerotic pathways. 10 Despite these findings suggesting the importance of lowerextremity arterial stiffness in lower-extremity blood flow and its association with LV hypertrophy, there have been only a few studies identifying determinants of lower-extremity arterial stiffness. Most of these studies determined lower-extremity arterial stiffness from local femoral arterial distensibility. Measurement of local vascular distensibility is often confounded by pressure most often measured at the brachial level and not locally, resulting in amplification-related errors. In addition, previous studies have reported the effect of lowerextremity peripheral arterial disease (PAD) on brachial-ankle PWV, but no study has determined the effect of lower-extremity arterial stenosis on lePWV.
The aim of the present study was to compare the effect of cardiovascular risk factors on lower-extremity and aortic stiffness. In order to determine the effect of lower-extremity peripheral arterial disease on lower-extremity arterial stiffness, lePWV was compared in patients with a low, normal and high ankle-brachial index.
METHODS

Study population
The Czech post-MONICA study is a population survey studying trends and determinants of cardiovascular risk factors in a random sample of the Czech population. Methods of the Czech post-MONICA study have been described elsewhere. 11 Our study included patients aged 425 years, residing in Pilsen district. The response rate in this district was 68%. A total of 911 patients (98% of patients examined in Pilsen district) had complete data on ABI and PWV. The study was approved by the local ethics committee of the Institute for Clinical and Experimental Medicine and Thomayer University Hospital, and was in accordance with the Declaration of Helsinki.
Hypertension was defined as systolic blood pressure (SBP) X140 mm Hg and/or diastolic blood pressure (DBP) X90 mm Hg, or current use of antihypertensive medication. Diabetes was defined as fasting plasma glucose X7.0 mmol l À1 or use of oral antidiabetic drugs and/or insulin. Dyslipidemia was defined as total cholesterol X5 mmol l À1 or high density lipoproteincholesterol o1 mmol l À1 in men and o1.2 mmol l À1 in women or use of lipid-lowering drugs. Chronic kidney disease (CKD) was defined as estimated glomerular filtration rate (eGFR) o60 ml min À1 per 1.73 m 2 . Glomerular filtration rate was estimated using the simplified CKD-EPI formula as described by Levey. 12 Measurement of large artery properties Large artery properties were measured using the SphygmoCor device (AtCor Medical Ltd, West Ryde, New South Wales, Australia) in the recumbent position as reported before. 13 Aortic pulse wave velocity and lePWV were assessed according to recommendations. 14 Consecutive registrations of the pulse waves are ECG-gated and thus, the time shift (Dt) between the foot of wave at the first and second sites can be calculated. The distance between the two sites was measured on the body surface. To determine aPWV, we measured the distance from the jugular fossa to the pulsation of the femoral artery in the groin and subtracted the distance from the jugular fossa to carotid pulsation in order to obtain the traveled distance (D). The distance between the femoral artery and dorsal pedal/posterior tibial arteries was measured to calculate lePWV. PWV was calculated as D (m)/Dt (s).
Doppler ABI measurement
Details of ABI measurement are described in our previous paper. 15 Briefly, appropriately sized cuffs of a mercury sphygmomanometer (Baumanometer TM, WA Baum, New York, NY, USA) were placed proximal to the ankles and on the right arm. After a 5 min resting period, SBP was measured on the right brachial artery, right dorsal pedal and posterior tibial arteries, left dorsal pedal and tibial arteries (in this order) using a pocket Doppler device with an 8 MHz probe (DopplexmultiTM, Huntleigh, Cardiff, UK). All measurements were performed by two physicians experienced in ABI measurement. ABI was calculated separately for each leg by dividing the highest of the ankle systolic pressures by the brachial systolic pressure. The lower of the two leg ABI values was used in further analysis. Systolic blood pressure measured on the right posterior tibial artery was used for further analyses and is indicated as ankle blood pressure (aSBP). A cutoff value of 175 mm Hg was used to identify subjects with increased aSBP as reported earlier. 16 
Statistical analysis
Descriptive statistics are given as mean ± s.d., mean (95% CI) or frequency and percent. In the figures, error bars represent s.e.m. In order to determine the effect of age and gender on arterial stiffness, analysis of covariance with adjustment for mean arterial pressure (MAP) was performed while subdividing individuals into quintiles of age. The effect of cardiovascular risk factors on arterial stiffness was determined by analysis of covariance with adjustment for age, gender and MAP. Partial eta-squared (Z 2 p ) is reported, indicating how much variability of the dependent variable can be predicted by the independent variable. The effect size was considered large for Z 2 p 40.30. To determine the effect of PAD on arterial stiffness, participants were divided into three groups on the basis of their ABI: low (ABIo1.0), normal (ABI ¼ 1-1.4), and high (ABIX1.4). Arterial properties between these groups were compared using one-way analysis of variance with Turkey's post-hoc test. Differences between groups were reassessed after adjustment for age, gender and MAP. Determinants of aPWV, lePWV and aSBP were assessed by multiple linear regression analysis. Variables significantly associated with parameters of arterial stiffness in univariate analyses were included into the multiple regression analyses. Standardized values of the mean and the systolic blood pressure were used to decrease colinearity between parameters. We considered the stability of the regression model to be disturbed by multi-colinearity if the tolerance was o0.1. Standardized beta is reported ( S ). A S of 0.1 indicates that when the independent variable increases by 1 s.d., the dependent variable increases by 0.1 s.d. All calculations were performed using SPSS 16 software (SPSS, Chicago, IL, USA). A two-sided P-value o0.05 was considered to be statistically significant.
RESULTS
Study population characteristics
Characteristics of the study population of 911 individuals (430 male and 481 female; mean age of 54.1 ± 13.49 years), with complete data, are provided in Table 1 .
Effect of age and gender on aortic and lower-extremity pulse wave velocities Aortic pulse wave velocity increased with age (Po0.001) both in men and women, with the mean aPWV higher in men (Figure 1 ). Partial eta-squared representing explained variability was high for age (Z 2 p ¼ 0.32), while there was only a minor effect of gender (Z 2 p ¼ 0.01). No interaction between age and gender was found (P ¼ 0.68).
Mean lower-extremity pulse wave velocity was higher in men than in women and showed a significant increase with age. There was a (Figure 2 ). When individuals with low ABI were excluded from the analysis of age and gender effect on lePWV, the age-gender interaction was no longer significant (P ¼ 0.12), while the Z 2 p for age and gender increased. Table 2 summarizes the effect of different cardiovascular risk factors on aPWV and lePWV. In unadjusted analyses, subjects with hypertension, diabetes and dyslipidemia had higher aPWV. The effect of these risk factors on aPWV remained unchanged after adjustment for covariates. Lower-extremity arterial stiffness was higher in individuals with hypertension and dyslipidemia. However, after adjustment, only hypertension remained associated with elevated lePWV. The effect of cardiovascular risk factors on lePWV did not change significantly after excluding individuals with low ABI.
Effect of cardiovascular risk factors on aPWV and lePWV
Association of aPWV and lePWV with lower-extremity peripheral arterial disease Aortic pulse wave velocity was higher in subjects with low and high ABI compared with the normal ABI group (high ABI, 11.1 ± 2.8 vs.
8.3 ± 2.3, Po0.0001; low ABI, 10.8 ± 2.5 vs. 8.3 ± 2.3, Po0.0001, respectively). There was no difference in aPWV between patients with low and high ABI (P ¼ 0.86). The elevation of aPWV in both extreme ABI groups remained unchanged after adjustment for age, gender and MAP (Figure 3a ). There was a linear increase in lePWV with increasing ABI (Po0.001 for linear trend). Lower-extremity PWV was lowest in individuals in the low ABI group (8. (Figure 3b ).
Determinants of aPWV and lePWV
In univariate analyses, the following parameters were associated with aPWV: age, MAP, SBP, DBP, serum cholesterol, waist circumference, triglycerides, glucose, creatinine level, eGFR, waist circumference, lePWV, heart rate and aSBP. In a multivariate model of linear regression (Table 3) , age had the largest effect on aPWV, explaining 36% of the total variance. Among the conventional cardiovascular risk factors, MAP, SBP, abdominal obesity and CKD were independently associated with aortic stiffness. Lower-extremity SBP was also associated with aPWV independently of brachial SBP and other cardiovascular risk factors. Individuals with aSBP 4175 mm Hg had higher aPWV at all levels of brachial blood pressure (Figure 4) , which suggests that ankle systolic blood pressure is associated with aortic stiffness independently of brachial systolic blood pressure. In the receiver operating characteristic analysis (area under the curve ¼ 0.71±0.02, Po0.001), after excluding individuals with low ABI, aSBP 4175 mm Hg had a sensitivity of 58% and a specificity of 84% to detect subjects with aPWV 410 m s À1 .
In univariate analyses, the following parameters were associated with lePWV: SBP, DBP, MAP, aSBP, age, weight, hip circumference, eGFR, serum creatinine, aPWV and glucose levels. In the multivariate model of linear regression (Table 3) , aSBP, age, gender, MAP, low ABI and hip circumference were independent predictors of lePWV.
In multiple regression analyses, after excluding individuals with low ABI, ankle blood pressure was determined by brachial SBP, MAP, aPWV, height, age and lePWV. Aortic stiffness ( S ¼ 0.11, Po0.001, R 2 ¼ 0.02) had a larger effect on ankle blood pressure than lePWV ( S ¼ 0.06, Po0.001, R 2 ¼ 0.004).
DISCUSSION
In this study, we compared the determinants of aortic stiffness with those of lower-extremity arterial stiffness. We observed that the effect of cardiovascular risk factors on arterial stiffness differed between these two arterial territories. The principal findings of our study are as follows: (1) age and cardiovascular risk factors such as hypertension, Lower-extremity vs. aortic stiffness P Wohlfahrt et al diabetes, dyslipidemia and chronic kidney disease affect aortic stiffness, while only age and hypertension have a significant effect on lower-extremity stiffness, (2) abdominal obesity increases aortic stiffness, while a larger hip circumference is associated with lowerextremity stiffness, (3) increased ankle systolic blood pressure is associated with increased aortic stiffness independently of brachial systolic pressure and other cardiovascular risk factors, (4) lowerextremity arterial stiffness is spuriously decreased in individuals with lower-extremity PAD. In our study, age had a major effect on aortic stiffness, but only a small effect on lower-extremity arterial stiffness. This may be due to the different histological structure of these arteries and a different effect of aging on these structures. In elastic arteries, aging leads to fragmentation and alteration of the elastic fiber network responsible for buffering function, while aging in the muscular arteries leads to changes in the extracellular matrix involving mainly collagen fibers, and to hypertrophy of vascular smooth muscle cells and the arterial wall, acting in the opposite direction on arterial stiffness. 17, 18 Indeed, there is general agreement that aortic stiffness increases with age, but there are discrepant data on aging of the lower-extremity arteries. While, in some studies, 19, 20 no increase in femoral artery stiffness with age was found, there was some increase in femoral 21 and lower limb arterial stiffness [22] [23] [24] in others. This discrepancy can be explained by the small effect of age on lePWV and different methods of arterial stiffness measurement.
We found hypertension to increase lower-extremity arterial stiffness. However, in other studies, 25, 26 hypertension had no effect or it decreased brachial artery stiffness. Of note, the brachial artery is also less prone to atherosclerosis than major arteries in the lower extremities. This suggests that differences in muscular arteries do exist.
We found a significant gender difference in aPWV and lePWV that was independent of anthropometric parameters and blood pressure. The effect of gender on stiffness was small as evident from the small Z 2 p . We found a significant age-gender interaction on lePWV that became non-significant after excluding individuals with PAD. This was probably due to the higher prevalence of men with PAD. The gender difference in lePWV observed in our study is in agreement with previous reports. 20, 27, 28 In our study, abdominal obesity expressed as waist circumference was associated with increased aPWV. Waist circumference is closely associated with visceral fat mass. Increased intraabdominal fat is known to contribute to hyperglycemia and hyperinsulinemia due to increased secretion of free fatty acids. These factors are known to affect aortic stiffness. The closer association of waist circumference with visceral fat and cardiovascular risk factors than BMI 29 explains why waist circumference was associated with aPWV in multiple regression analysis, while BMI was not. Our finding is in agreement with previous reports 30, 31 in which only waist circumference was independently associated with aortic stiffness, while BMI, hip circumference, fat mass, fat free mass and the waist/hip ratio were not. While waist circumference was associated with increased aPWV, we found increased hip circumference to be linked to lower lePWV. This finding is in agreement with the results of the Hoorn study, in which larger leg fat mass and leg lean mass were associated with lower peripheral arterial stiffness. This may be one of the explanations why increased hip circumference is associated with lower cardiovascular risk in population studies, 32 and why the gynoid type of obesity is less deleterious than the android one.
Another new finding is the association between aSBP and aPWV that was independent of cardiovascular risk factors including brachial SBP. Furthermore, we found aSBP to be more closely related to aortic stiffness than to lePWV. This suggests that aSBP is more a parameter of aortic stiffness than that of lower-extremity stiffness. Increased transmission of pulsatile energy to the periphery due to increased aortic stiffness may be the potential mechanism explaining association between aSBP and aPWV. 33 Increased pulsatile stress to the peripheral circulation due to aortic stiffening is caused by loss of buffering function of aorta and impedance mismatch loss between aorta and peripheral circulation. Normally, wave reflection occurs due to arterial stiffness mismatch between the aorta and large muscular arteries. 
Figure 4
Effect of bSBP and aSBP on aortic pulse wave velocity. aSBP, ankle systolic blood pressure; aPWV, aortic pulse wave velocity; bSBP, brachial systolic blood pressure.
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Partial wave reflection protects microcirculation from the damaging effect of pulsatile energy. As aortic stiffness meets the stiffness of large muscular arteries, wave reflection is reduced and more pulsatile energy is transmitted to the periphery. Our results suggest that increased aSBP is linked to increased aortic stiffness and may be a parameter of increased pulsatile energy transmission to the periphery. To confirm this theory, energy waves in posterior tibial artery will have to be assessed in the future. The association between aSBP and aortic stiffness may explain the observed positive association between lower-extremity stiffness and LV mass, which is independent of subclinical atherosclerosis. 10 The independent predictive role of the aSBP in cardiovascular prediction was described previously. In a population study, 16 aSBP 4175 mm Hg was an independent predictor of total and cardiovascular mortality in asymptomatic individuals independently of all traditional cardiovascular risk factors. In another study, aSBP improved the prediction of cardiovascular events independently of classical risk factors. 34 Further studies will be needed to assess the predictive role of ankle SBP in cardiovascular prediction. The advantage of the aSBP examination is that it is fast, non-invasive, feasible and widely available.
We found decreased lePWV in individuals with lower-extremity PAD (low ABI group). We think that this is an artifact due to significant stenosis. The explanation of this phenomenon can be the blood pressure decrease behind stenosis. Distending pressure is one of the major determinants of arterial stiffness. Moreover, pressure waveform changes have been reported in patients with PAD. Among other things, delay in the foot of the waveform has been reported in patients with PAD compared with normal subjects. 35 It is the foot of the pulse wave that is commonly used for time delay calculation in order to estimate PWV. Another explanation is the increase in the distance traveled due to collateral circulation. The effect of PAD on brachial-ankle PWV (baPWV) was described previously. Yokoyama et al. 36 reported baPWV reduction in a leg affected with PAD compared with the non-affected leg. Moreover, baPWV increased following successful stenosis dilatation. In another study, an ABI of 0.95 was calculated to be the cutoff value for diminished accuracy of baPWV. 37 In the current study, we estimated the aortic length by subtracting the jugular fossa to the carotid pulsation distance from the jugular fossa to the femoral artery pulsation side. This method is known to underestimate the true aortic stiffness. The current consensus for aortic stiffness measurement is to use 80% of the direct distance between carotid and femoral measurement sides with the cutoff value of 10 m s À1 . 14 However, this has no effect on the strength of association with cardiovascular risk factors and the conclusions of our study.
Our results suggest that conventional cardiovascular risk factors, except for hypertension, have only a small effect on lower-extremity arterial stiffness. The effect of aortic stiffness on peripheral vasculature may be explained by increased pulsatile energy transmission to the periphery due to increased aortic stiffness. Increased ankle systolic blood pressure may be a parameter of increased pulsatile energy transmission to the periphery. Further research is needed to evaluate energy waves in lower-extremity arteries and to confirm the association between increased ankle blood pressure and microcirculation damage.
